US court invalidates King’s two US patents for muscle relaxant
The company plans to appeal the order, which was issued in response to Eon’s motion for summary judgment without the benefit of a hearing. Furthermore, the order is
Voro Therapeutics and Alloy Therapeutics have formed a strategic research partnership to develop tumour-selective, next-generation masked T-cell engager (TCE) therapeutics.
The acquired Medivices technology involves designing, marketing and manufacturing new innovative medical devices using nanomedicine and Micro-ElectroMechanical Systems. The acquisition includes all patent and proprietary rights and property